Member Info for Humblepie

I wonder why? Are we going to get some attention soon here? As of today 4th July 11.6 million is it going to change? Any activity coming this way? Hello anyone out there?

http://www.investegate.co.uk/Article.aspx?id=201006230700070663O

I know astr is not looking healthy with that 66% spread...

GlobalCrossing

Whats the story here can't be bothered to research....

Zara is over on ppa today which was quite good ealier nothing like your ealier foray thogh....

When you add a bit of expected news to that warm and fuzzy feeling who know what will happen, if your not sure of something better not do it in my opnion, its got to be a cert......

Just watchig you mate:

Are we going to get this share moving?

Thought I would find you here.....

16 June 2010 DRAGON OIL PLC (the "Company" or together with its subsidiaries "Dragon Oil" or the "Group") New marketing contract through Baku, Azerbaijan Dragon Oil plc (Ticker: DGO), an international oil and gas exploration and production company, today issued the following update on its crude oil marketing arrangements. Since the commencement of its Cheleken PSA, Dragon Oil has marketed most of its entitlement barrels through a crude oil swap agreement with a subsidiary of the National Iranian Oil Company, Naftiran Company Limited ('NICO'), the "southern route". This swap agreement expired on 31 March 2010 and Dragon Oil subsequently entered into a three month swap contract with NICO which will expire in July, 2010. The swap will then be halted until further negotiations are concluded. Dragon Oil has entered into a contract with Socar Trading SA for the sale of the Company's entitlement barrels, FOB the Aladja Jetty, through Baku, Azerbaijan, the "western route". Socar Trading, the trading arm of the State Oil Company of Azerbaijan Republic, will make use of the BP-operated BTC (Baku-Tbilisi-Ceyhan) pipeline for exporting the crude oil. Dragon Oil has had previous contracts with Socar Trading for the sale of its crude oil through the western route which have operated successfully. Dragon Oil plans to sell a substantial proportion of its entitlement production through the western route over the next 12 months. It is expected that the realised net crude oil prices will be less favourable than the historic netback prices generated through the southern route swap arrangement with NICO. For the year to 31 December 2010, discounts were favourable during the early part of the year, and over the entire year, Dragon Oil expects to achieve an average realised price in the range of a US$6-8 discount per barrel to Brent. Discounts in future years may vary depending on the renewal of the swap agreement or availability of alternatives. Dragon Oil is satisfied that this new marketing arrangement will provide a secure and reliable export route for its entitlement production with sufficient capacity to satisfy its current anticipated needs. Nonetheless, to gain further access to international markets and maintain flexibility in operations, Dragon Oil will continue to review alternative routes for exporting its crude oil, while a return to the southern route remains an option should terms become more favourable. Dr Abdul Jaleel Al Khalifa, Chief Executive Officer, commented: "Dragon Oil's primary marketing and sales objective is to ensure the safe and uninterrupted sale and delivery of its entitlement barrels to international markets, and to achieve best available market prices, subject to logistical considerations and market conditions. I am pleased that Dragon Oil has entered into this contract with Socar Trading, which ha

Some people just do not get it do they. You would think by now what trading is all about but they don't. Me make money? What ever gave you that idea? I just love typing letters to my favourite posters......(you have to admit you were a bit slow this morning, whats up?)

Its called buying and selling, and that is the name of the game. You'll learn..........

Is that £5.4 million or something around that figure as a quick guess?

15 June 2010 Tinci Holdings Limited ("Tinci" or the "Company") Contract Win Tinci Holdings Ltd. (AIM: TNCI), the AIM quoted environmental engineering company, announces that the Company has signed an RMB 54.5 million contract with Shandong Chiping Xinyuan Aluminium Co. Ltd. ("Xinyuan"). The contract is for two 360MW installations and will use traditional wet limestone Flue Gas Desulfurisation (FGD) technology. This project is expected to start in June 2010 and last for approximately 12 months. The signing of this contract demonstrates the confidence of Xinfa Aluminium Industry Group ("Xinfa"), the parent company of Xinyuan based in China, in using Tinci's FGD technology. It is the 20th FGD project which Xinfa has awarded to Tinci to address its desulfurisation needs since 2005.

Phytopharm receives USA regulatory approval to begin Phase II clinical trial of Cogane™ Patient enrolment is planned to begin in late 2010 GODMANCHESTER, Cambridgeshire, UK, 14 June 2010 - Phytopharm plc (LSE: PYM) ("Phytopharm" or "the Company") today announces that the Company's investigational new drug (IND) application for its lead pharmaceutical candidate Cogane™ for the treatment of Parkinson's disease has been granted by the US Food and Drug Administration (FDA). The FDA has agreed the protocol for the Phase II proof of concept trial with Phytopharm. The study will investigate the efficacy, safety and tolerability of CoganeTM administered for 28 weeks to patients with early stage Parkinson's disease. The primary endpoint for the study will be the change in activities of daily living and motor function as measured by the Unified Parkinson's Disease Rating Scale (UPDRS) Parts II and III. Other efficacy endpoints include assessment of cognitive function and quality of life. Safety assessments include standard ECG assessment, effects on blood pressure and pulse, and haematology and clinical chemistry monitoring. The study will be conducted in a number of countries, including the USA and the UK, and regulatory submissions in the other countries will be submitted shortly. Preparatory work is continuing with Contract Research Organisations (CROs) who will conduct the study on behalf of Phytopharm. The Company expects recruitment of patients into the study to commence in the next 6 months. Sandy Morrison, Interim CEO, said: "This IND for Cogane™ is an important milestone for Phytopharm. It confirms the quality of our preclinical data and development plan. We look forward to the enrolment of patients in this Phase II trial, but recognise that it will be about 2 years before we have definitive results from the study. Nevertheless this is an important next step towards bringing a potentially disease-modifying new therapy for Parkinson's disease closer to market fruition." -Ends-

Sorry for speaking out of line on the ast board on Tuesday about tnci

The nature of a warrent is such. You can be in the money. Or you can be out of the money. If they are not exercised by the time period they expire. (That means they are worthless) They are very similar to options which give you the right to buy something by a certain time. However there is a difference. Some times they are not worth exercising. They are also like nil paid rights you can sell them if you wish. Anything less than a couple of thousand is not worth much. The question is do you want to exericise them and buy more shares or sell them on for the difference in value?

300% Spread

mta